UBS Group
TDAC

UBS Group’s Translational Development Acquisition Corp TDAC Stock Holding History

UBS Group’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,692
Closed -$187K – 11373
2026
Q1 		$187K Buy
17,692
+5,009
+39% +$52.8K ﹤0.01% 6677
2025
Q4 		$133K Sell
12,683
-21,367
-63% -$223K ﹤0.01% 6769
2025
Q3 		$352K Buy
34,050
+34,031
+179,111% +$351K ﹤0.01% 6333
2025
Q2 		$195 Hold
19
– – ﹤0.01% 9932
2025
Q1 		$192 Buy
+19
New +$191 ﹤0.01% 9892

Other funds holding TDAC

LA
Linden Advisors New York $19.3B AUM 1.46% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.39% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.56% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.47% 1-Year Est. Return

UBS Group's TDAC Position: Q2 2026 in Review

UBS Group sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 17,692 shares — an estimated $187K sold.

UBS Group first reported a position in TDAC in Q1 2025 and held it in 5 quarters. The position peaked at $352K in Q3 2025. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • UBS Group reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 17,692 Translational Development Acquisition Corp shares in Q2 2026, an estimated $187K.
  • UBS Group first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 5 quarters.
  • UBS Group's Translational Development Acquisition Corp position peaked at $352K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.